Verve’s gene-editing therapy trial to lower cholesterol levels opens doors for use in CVDs: GlobalData Read more
First-in-class DLL3-targeting BiTE could be the next big player in SCLC treatment: GlobalData Read more
Zydus NCE drugs will see improved market penetration with new partnerships in India: GlobalData Read more
Biocon Biologics signs pact with Eris Lifesciences for divesture of dermatology and nephrology branded formulations business units in India Read more